Predicting adverse drug reaction outcomes with machine learning

Authors

  • Andy W. Chen University of British Columbia, 2053 Main Mall, Vancouver, BC, V6T 1Z2, Canada

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20180744

Keywords:

Drug-related side effects, Adverse reactions, Adverse drug reaction reporting systems, Drug interactions, Statistical models

Abstract

Background: Adverse drug reactions are a drug safety issue affecting more than two million people in the U.S. annually. The Food and Drug Administration (FDA) maintains a comprehensive database of adverse drug reactions reported known as FAERS (FDA adverse event reporting system), providing a valuable resource for studying factors associated with ADRs. The goal of the project is to build predictive models to predict the outcome given patient characteristics and drug usage. The results can be valuable for health care practitioners by offering new knowledge on adverse drug reactions which can be used to improve decision making related to drug prescriptions.

Methods: In this paper I present and discuss results from machine learning models used to predict outcomes of ADRs. Machine learning models are a popular set of models for prediction. They have gained attention recently and have been used in a variety of fields. They can be trained on existing data and retrained when new data become available. The trained models are then used to make predictions.

Results: I find that the supervised learning models are work similarly within groups, with accuracy between 65% and 75% for predicting deaths and 70% to 75% for predicting hospitalizations. Across groups the models predict hospitalizations better than deaths.

Conclusions: The predictive models I built achieve good accuracy. The results can potentially be improved when more data become available in the future.

Metrics

Metrics Loading ...

References

Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-9.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association. 1998;279(15):1200-5.

Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(1):S73-7.

Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–11.

Kadoyama K, Kuwahara A, Yamamori M, Brown JB, Sakaeda T, Okuno Y. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS. Journal of Experimental & Clinical Cancer Research. 2011;30:93.

Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956–66.

Lassila HC, Stoehr GP, Ganguli M, Seaberg EC, Gilby JE, Belle SH, et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother. 1996;30:589–95.

Cooper JW. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatric Soc. 1996;44:194–7.

Tsymbal A, Pechenizky M, Cunningham P, Puuronen S. Dynamic integration of classifiers for handling concept drift. Information Fusion. 2008;9(1):56-68.

Downloads

Published

2018-02-24

How to Cite

Chen, A. W. (2018). Predicting adverse drug reaction outcomes with machine learning. International Journal Of Community Medicine And Public Health, 5(3), 901–904. https://doi.org/10.18203/2394-6040.ijcmph20180744

Issue

Section

Original Research Articles